Simvastatin attenuates TNF-α-induced apoptosis in endothelial progenitor cells via the upregulation of SIRT1

International Journal of Molecular Medicine

Volumn 34, Issue 1, 2014, Pages 177-182

  Du, Gang ^a   Song, Yunlin ^b   Zhang, Tao ^a   Ma, Long ^b   Bian, Ning ^a   Chen, Xiaoming ^a   Feng, Jianyi ^a   Chang, Qing ^c   Li, Zicheng ^a  

^a JINAN UNIVERSITY   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

^c MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

Apoptosis; Endothelial progenitor cells; Silent information regulator type 1; Simvastatin; Tumor necrosis factor

Indexed keywords

SIMVASTATIN; SIRTUIN 1; TUMOR NECROSIS FACTOR ALPHA; HYPOCHOLESTEROLEMIC AGENT; SIRT1 PROTEIN, HUMAN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIME; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; FETUS BLOOD; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

ANTICHOLESTEREMIC AGENTS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL PROGENITOR CELLS; FETAL BLOOD; HUMANS; SIGNAL TRANSDUCTION; SIMVASTATIN; SIRTUIN 1; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84902690129     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1740     Document Type: Article

References (51)

1. Rouhl RP, van Oostenbrugge RJ, Damoiseaux J, Tervaert JW and Lodder J: Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts. Stroke 39: 2158-2165, 2008.
2. Decano JL, Moran AM, Giordano N, Ruiz-Opazo N and Herrera VL: Analysis of CD45- [CD34+/KDR+] endothelial progenitor cells as juvenile protective factors in a rat model of ischemic-hemorrhagic stroke. PLoS One 8: e55222, 2013.
3. Huang H, Huang F and Huang JP: Transplantation of bone marrow-derived endothelial progenitor cells overexpressing Delta-like-4 enhances functional neovascularization in ischemic myocardium. Mol Med Rep 8: 1556-1562, 2013.
4. Thal MA, Krishnamurthy P, Mackie AR, et al : Enhanced angiogenic and cardiomyocyte differentiation capacity of epigenetically reprogrammed mouse and human endothelial progenitor cells augments their efficacy for ischemic myocardial repair. Circ Res 111: 180-190, 2012.
5. Patschan D, Hildebrandt A, Rinneburger J, et al: The hormone melatonin stimulates renoprotective effects of 'early outgrowth' endothelial progenitor cells in acute ischemic kidney injury. Am J Physiol Renal Physiol 302: F1305-F1312, 2012.
6. Bouchentouf M, Forner K, Cuerquis J, et al: A novel and simplified method of culture of human blood-derived early endothelial progenitor cells for the treatment of ischemic vascular disease. Cell Transplant 20: 1431-1443, 2011.
7. Głowińska-Olszewska B, Luczyñski W and Bossowski A: [Endothelial progenitor cells as a new marker of endothelial function with respect to risk of cardiovascular disorders]. Postepy Hig Med Dosw (Online) 65: 8-15, 2011 (In Polish).
8. Shantsila E, Watson T and Lip GY: Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 49: 741-752, 2007.
9. Sun JY, Zhai L, Li QL, et al: Effects of ACE inhibition on endothelial progenitor cell mobilization and prognosis after acute myocardial infarction in type 2 diabetic patients. Clinics (Sao Paulo) 68: 665-673, 2013.
10. Sandri M, Beck EB, Adams V, et al: Maximal exercise, limb ischemia, and endothelial progenitor cells. Eur J Cardiovasc Prev Rehabil 18: 55-64, 2011.
11. Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher AM and Dimmeler S: Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 114: 2823-2830, 2006. (Pubitemid 46018285)
12. Jiménez-Navarro MF, González FJ, Caballero-Borrego J, et al: [Coronary disease extension determines mobilization of endothelial progenitor cells and cytokines after a first myocardial infarction with ST elevation]. Rev Esp Cardiol 64: 1123-1129, 2011 (In Spanish).
13. Bonello L, Harhouri K, Baumstarck K, et al: Mobilization of CD34+ KDR+ endothelial progenitor cells predicts target lesion revascularization. J Thromb Haemost 10: 1906-1913, 2012.
14. Kim JY, Park YJ, Kim KJ, Choi JJ, Kim WU and Cho CS: Osteoprotegerin causes apoptosis of endothelial progenitor cells by induction of oxidative stress. Arthritis Rheum 65: 2172-2182, 2013.
15. Chen J, Huang L, Song M, Yu S, Gao P and Jing J: C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells. J Cardiovasc Pharmacol 53: 359-367, 2009.
16. Skoog T, Dichtl W, Boquist S, et al: Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J 23: 376-383, 2002. (Pubitemid 35204198)
17. Ruan W, Xu JM, Li SB, Yuan LQ and Dai RP: Effects of down-regulation of microRNA-23a on TNF-α -induced endothelial cell apoptosis through caspase-dependent pathways. Cardiovasc Res 93: 623-632, 2012.
18. Markelic M, Velickovic K, Golic I, et al: Endothelial cell apoptosis in brown adipose tissue of rats induced by hyperinsulinaemia: the possible role of TNF-α. Eur J Histochem 55: e34, 2011.
19. Nystrom T, Nygren A and Sjoholm A: Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction. Clin Sci (Lond) 110: 673-681, 2006. (Pubitemid 43844737)
20. Speciale A, Canali R, Chirafisi J, Saija A, Virgili F and Cimino F: Cyanidin-3-O-glucoside protection against TNF-α-induced endothelial dysfunction: involvement of nuclear factor-κB signaling. J Agric Food Chem 58: 12048-12054, 2010.
21. Henrich D, Seebach C, Wilhelm K and Marzi I: High dosage of simvastatin reduces TNF-alpha-induced apoptosis of endothelial progenitor cells but fails to prevent apoptosis induced by IL-1beta in vitro. J Surg Res 142: 13-19, 2007. (Pubitemid 47267991)
22. Seeger FH, Haendeler J and Walter DH, et al : p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111: 1184-1191, 2005. (Pubitemid 40365481)
23. Ziedén B and Olsson AG: The role of statins in the prevention of ischemic stroke. Curr Atheroscler Rep 7: 364-368, 2005. (Pubitemid 41684210)
24. Margaritis M, Channon KM and Antoniades C: Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering. Antioxid Redox Signal 20: 1198-1215, 2014.
25. Zhu Y, Casey PJ, Kumar AP and Pervaiz S: Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases. Cell Death Dis 4: e568, 2013.
26. Piechota-Polanczyk A, Goraca A, Demyanets S, et al: Simvastatin decreases free radicals formation in the human abdominal aortic aneurysm wall via NF-κB. Eur J Vasc Endovasc Surg 44: 133-137, 2012.
27. Fuhrmeister J, Tews M, Kromer A and Moosmann B: Prooxidative toxicity and selenoprotein suppression by cerivastatin in muscle cells. Toxicol Lett 215: 219-227, 2012.
28. Hoffmann G, Breitenbücher F, Schuler M and Ehrenhofer-Murray AE: A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer. J Biol Chem 289: 5208-5216, 2014.
29. Nihal M, Ahmad N and Wood GS: SIRT1 is upregulated in cutaneous T-cell lymphoma and its inhibition induces growth arrest and apoptosis. Cell Cycle 13: 632-640, 2014.
30. Hori YS, Kuno A, Hosoda R and Horio Y: Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress. PLoS One 8: e73875, 2013.
31. Kim S, Bi X, Czarny-Ratajczak M, et al: Telomere maintenance genes SIRT1 and XRCC6 impact age-related decline in telomere length but only SIRT1 is associated with human longevity. Biogerontology 13: 119-131, 2012.
32. Kok SH, Lin LD, Hou KL, et al: Simvastatin inhibits cysteine-rich protein 61 expression in rheumatoid arthritis synovial fibroblasts through the regulation of sirtuin-1/FoxO3a signaling. Arthritis Rheum 65: 639-649, 2013.
33. Ota H, Eto M, Kano MR, et al: Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway. Arterioscler Thromb Vasc Biol 30: 2205-2211, 2010.
34. Dimitrova KR and Leitman IM: Intramyocardial transplantation of endothelial progenitor cells and erythropoietin: a new scope for the treatment of cardiovascular disease. J Surg Res 183: 550-552, 2013.
35. Hu CH, Ke X, Chen K, Yang DY, Du ZM and Wu GF: Transplantation of human umbilical cord-derived endothelial progenitor cells promotes re-endothelialization of the injured carotid artery after balloon injury in New Zealand white rabbits. Chin Med J (Engl) 126: 1480-1485, 2013.
36. Liu P, Zhou B, Gu D, Zhang L and Han Z: Endothelial progenitor cell therapy in atherosclerosis: a double-edged sword? Ageing Res Rev 8: 83-93, 2009.
37. Du G, Zhou L, Ghang Q and Li Z: Inhibitory effect of simvastatin on replicative senescence of endothelial progenitor cells and its mechanism. J Jilin Univ (Medicine Edition) 39: 913-918, 2013.
38. Thum T, Fraccarollo D, Galuppo P, et al: Bone marrow molecular alterations after myocardial infarction: impact on endothelial progenitor cells. Cardiovasc Res 70: 50-60, 2006.
39. Tousoulis D, Oikonomou E, Siasos G and Stefanadis C: Statins in heart failure - with preserved and reduced ejection fraction. An update. Pharmacol Ther 141: 79-91, 2014.
40. Balakumar P, Kathuria S, Taneja G, Kalra S and Mahadevan N: Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins? J Mol Cell Cardiol 52: 83-92, 2012.
41. Xu S, Zhao Y, Yu L, Shen X, Ding F and Fu G: Rosiglitazone attenuates endothelial progenitor cell apoptosis induced by TNF-α via ERK/MAPK and NF- κB signal pathways. J Pharmacol Sci 117: 265-274, 2011.
42. Yuan H, Wang Z and Li L, et al: Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis. Blood 119: 1904-1914, 2012.
43. Huang PS, Son JH, Abbott LC and Winzer-Serhan UH: Regulated expression of neuronal SIRT1 and related genes by aging and neuronal β2-containing nicotinic cholinergic receptors. Neuroscience 196: 189-202, 2011.
44. Jeong J, Juhn K, Lee H, et al: SIRT1 promotes DNA repair activity and deacetylation of Ku70. Exp Mol Med 39: 8-13, 2007. (Pubitemid 46356001)
45. Jin Q, Yan T, Ge X, Sun C, Shi X and Zhai Q: Cytoplasm-localized SIRT1 enhances apoptosis. J Cell Physiol 213: 88-97, 2007.
46. Kacimi R, Karliner JS, Koudssi F and Long CS: Expression and regulation of adhesion molecules in cardiac cells by cytokines: response to acute hypoxia. Circ Res 82: 576-586, 1998. (Pubitemid 28129028)
47. Wang W, Yan C, Zhang J, et al: SIRT1 inhibits TNF-α-induced apoptosis of vascular adventitial fibroblasts partly through the deacetylation of FoxO1. Apoptosis 18: 689-701, 2013.
48. Dvir-Ginzberg M, Gagarina V, Lee EJ, Booth R, Gabay O and Hall DJ: Tumor necrosis factor α-mediated cleavage and inactivation of SirT1 in human osteoarthritic chondrocytes. Arthritis Rheum 63: 2363-2373, 2011.
49. Zhang HN, Li L and Gao P, et al: Involvement of the p65/RelA subunit of NF-kappaB in TNF-alpha-induced SIRT1 expression in vascular smooth muscle cells. Biochem Biophys Res Commun 397: 569-575, 2010.
50. Yang J, Huang C, Yang J, Jiang H and Ding J: Statins attenuate high mobility group box-1 protein induced vascular endothelial activation: a key role for TLR4/NF-κB signaling pathway. Mol Cell Biochem 345: 189-195, 2010.
51. Ahn KS, Sethi G and Aggarwal BB: mReversal of chemoresistance and enhancement of apoptosis by statins through downregulation of the NF-κB pathway. Biochem Pharmacol 75: 907-913, 2008. (Pubitemid 351174113)